Vicinitas Therapeutics
San Francisco
About Vicinitas Therapeutics
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $65.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2022)
- Website: vicinitastx.com
Industries & Categories
Biotechnology, Life Science, Therapeutics
Canonical: https://fsome.com/organization/vicinitas-therapeutics-15700 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.